News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avant Immunotherapeutics (AVAN) CEO To Present at the UBS Warburg 2008 Global Life Sciences Conference September 23


9/19/2008 9:42:49 AM

NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Anthony S. Marucci, Interim President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the UBS 2008 Global Life Sciences Conference at the Grand Hyatt New York on Tuesday, September 23, at 2:30 pm, EDT.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES